Welcome to our dedicated page for Texas Instrument SEC filings (Ticker: TXN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Texas Instruments Incorporated filings document operating results, governance actions, capital-structure details and material events for a Nasdaq-listed semiconductor company. Form 8-K reports cover quarterly and annual results, furnished earnings releases, non-GAAP free cash flow measures and related reconciliations, as well as dividend and shareholder-return disclosures.
Proxy and annual meeting filings describe board elections, executive compensation votes, auditor ratification and other stockholder proposals. Additional 8-K disclosures record by-law amendments, forum-selection provisions, officer transition matters, registered common stock details and exhibits filed in Inline XBRL.
Texas Instruments submitted a Form 144 notifying the proposed sale of 6,125 shares of Common Stock through UBS Financial Services Inc for an aggregate amount of $1,656,283.36 with a proposed sale date of 04/27/2026.
The notice lists shares sourced from ESOP awards dated 01/24/2020 (1,100 shares) and 01/27/2022 (5,025 shares); proceeds are listed as cash.
UBS Financial Services Inc. submitted a Form 144 notice proposing the sale of 3,625 shares of common stock of Texas Instruments. The shares originate from ESOP grants dated 01/26/2017, 01/25/2018, 01/25/2019, and 01/24/2020. The filing lists a transaction date of 04/24/2026 and shows an aggregate value of $998,770.52. The sale method is described as cash and the broker listed is UBS Financial Services Inc.
Texas Instruments proposes resale of common shares via brokered cash transactions. The notice lists four blocks of common stock dated 01/25/2019, 01/24/2020, 01/28/2021, and 01/27/2022 totaling specified lot sizes; sale date on the form is 04/24/2026.
Texas Instruments reported a Form 144 notice of proposed sale of shares. The filing lists 40,541 shares of Common Stock associated with UBS Financial Services Inc. and identifies sales tied to an ESOP and RSU activity. The filing shows sales reported on 02/10/2026 and 02/11/2026 with a filing date of 04/24/2026.
Entity reported a Form 144 notice relating to common stock.
The filing lists 15,000 shares of common stock as "Securities To Be Sold" with an associated date of 04/24/2026. It also shows an earlier option exercise dated 01/31/2020 and a reported sale of 3,144 shares on 02/05/2026 for $11,670.00.
Texas Instruments reported strong Q1 2026 results with double‑digit growth. Revenue rose to $4.83 billion from $4.07 billion, driven mainly by higher demand in the Analog and Embedded Processing segments. Net income increased to $1.55 billion, and diluted EPS climbed to $1.68 from $1.28.
Analog revenue grew 22% to $3.92 billion with operating margin of 41.7%, while Embedded Processing revenue rose 12% to $723 million and sharply improved profitability. Trailing 12‑month free cash flow reached $4.35 billion, and the company returned $6.0 billion to shareholders. TI also agreed to acquire Silicon Labs for about $7.5 billion in cash, targeting closing in the first half of 2027.
Texas Instruments reported strong first-quarter 2026 results, with revenue of $4.83 billion, up 19% from a year earlier. Net income rose to $1.55 billion and diluted earnings per share reached $1.68, a 31% increase that included a 5‑cent benefit above the company’s original guidance.
Trailing 12‑month cash flow from operations was $7.82 billion and free cash flow was $4.35 billion, up 154% year over year, helped by CHIPS Act incentives. Over the past 12 months, TI returned $6.03 billion to shareholders through dividends and buybacks and invested heavily in R&D, SG&A and capital spending. For the second quarter, TI expects revenue between $5.00 billion and $5.40 billion and EPS between $1.77 and $2.05.
Texas Instruments Incorporated reported voting results from its April 16, 2026 annual stockholder meeting. Stockholders elected all board nominees, each receiving well over 600 million votes in favor, with sizable broker non-votes recorded.
Stockholders gave advisory approval to the company’s executive compensation, with 629,949,018 votes for and 127,448,980 against. They also ratified Ernst & Young LLP as independent registered public accounting firm for 2026, with 757,840,159 votes for. A stockholder proposal to permit action by written consent was not approved, receiving 338,654,128 votes for and 417,882,720 against.